Johnson & Johnson's organic growth and margin expansion remain moderate. Read why I would not add fresh capital to JNJ stock ...

Fintel reports that on December 15, 2025, B of A Securities maintained coverage of Johnson & Johnson (NYSE:JNJ) with a ...

Here’s a closer look at the top pharmaceutical companies that have earned favorable rankings from Wolfe Research analysts. Johnson & Johnson takes the top spot with growth primarily driven by new ...

Johnson & Johnson (JNJ) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock ...

FDA approves Johnson & Johnson's Akeega combo for BRCA2 metastatic prostate cancer after Phase 3 data showed major reductions ...

These Institutional Investors Are Raising Their Stakes in Johnson & Johnson Stock. Should You Do the Same? They might be on ...

Wondering if Johnson & Johnson is still a steady blue chip or a quietly undervalued opportunity? Let us unpack what the ...

Fintel reports that on December 11, 2025, Citigroup maintained coverage of Johnson & Johnson (NYSE:JNJ) with a Buy ...

Johnson & Johnson stock nears $200 after rally. Find out why analysts maintain a Hold rating on JNJ stock and a $220 price ...

The release of unexpectedly robust Phase 3 clinical trial data this week by healthcare giant Johnson & Johnson failed to move ...

If you bought 10 shares of Johnson & Johnson (JNJ) stock 10 years ago, this is how much it would be worth today.